SARS-CoV-2 Nucleocapsid Antibody, Rabbit, Polyclonal
Catalog Number:
NSJ-RQ6297
- Images (0)
| Article Name: | SARS-CoV-2 Nucleocapsid Antibody, Rabbit, Polyclonal |
| Biozol Catalog Number: | NSJ-RQ6297 |
| Supplier Catalog Number: | RQ6297 |
| Alternative Catalog Number: | NSJ-RQ6297 |
| Manufacturer: | NSJ Bioreagents |
| Host: | Rabbit |
| Category: | Antikörper |
| Application: | ELISA |
| Species Reactivity: | Human |
| Immunogen: | Amino acids MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWY FYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALA LLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTW LTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA were used as the immunogen for the SARS-CoV-2 Nucleocapsid antibody. |
| Alternative Names: | sars-cov-2 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined. The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The nucleocapsid phosphoprotein is a structural protein that binds to, protects the viral RNA genome and is involved in packaging the RNA into virus particles. The N protein has been suggested as an antiviral drug target. |
| Clonality: | Polyclonal |
| UniProt: | P0DTC9 |
| Buffer: | Lyophilized from 1X PBS with 2% Trehalose |
| Purity: | Affinity purified |
| Form: | 0.5mg/ml if reconstituted with 0.2ml sterile DI water |
| Antibody Type: | Primary Antibody |
| Application Dilute: | ELISA |
| Application Notes: | Optimal dilution of the SARS-CoV-2 Nucleocapsid antibody should be determined by the researcher. |
Product Guarantee and Expert Support
